Fingerprint
Dive into the research topics of 'BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression
Ilana Mandel, Dana Haves Ziv, Ilana Goldshtein, Tsuri Peretz, Dror Alishekevitz, Anna Fridman Dror, Motti Hakim, Sharon Hashmueli, Itay Friedman, Yair Sapir, Rita Greco, Hongjing Qu, Frank Nestle, Dmitri Wiederschain, Lily Pao, Sharad Sharma, Tehila Ben Moshe
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations